Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D001572:Benzofurans; D001578:Benzopyrans / Q000009:adverse effects*; D002110:Caffeine / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D019587:Dietary Supplements / Q000009:adverse effects*; D004104:Diiodothyronines / Q000009:adverse effects*; D017277:Drug Approval; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D010665:Phenylpropanolamine / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D015016:Yohimbine / Q000009:adverse effects*
D001572:Benzofurans; D001578:Benzopyrans; D004104:Diiodothyronines; D004338:Drug Combinations; C453460:lipokinetix; D015016:Yohimbine; D010665:Phenylpropanolamine; D002110:Caffeine